BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16609884)

  • 1. [Medico-legal aspects of the use of fentanyl patches].
    Zimmermann M
    Anaesthesist; 2006 Jun; 55(6):706-7. PubMed ID: 16609884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl patch for stable chronic pain in children: new indication. Used fentanyl patches should be handled with care.
    Prescrire Int; 2008 Jun; 17(95):104. PubMed ID: 18623912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fentanyl patches: preventable overdose.
    Prescrire Int; 2010 Feb; 19(105):22-5. PubMed ID: 20455338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proper use of fentanyl pain patches.
    Meadows M
    FDA Consum; 2006; 40(2):13-5. PubMed ID: 16671195
    [No Abstract]   [Full Text] [Related]  

  • 6. Transdermal fentanyl: new preparation. An alternative to morphine.
    Prescrire Int; 1998 Oct; 7(37):137-40. PubMed ID: 10915416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy].
    Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357
    [No Abstract]   [Full Text] [Related]  

  • 8. Using high-dose fentanyl patches.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Jul; 96(7):18-20, 22. PubMed ID: 8659562
    [No Abstract]   [Full Text] [Related]  

  • 9. In brief: heat and transdermal fentanyl.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of transdermal fentanyl patches in the effective management of cancer pain.
    Gibbs M
    Int J Palliat Nurs; 2009 Jul; 15(7):354-9. PubMed ID: 19648851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl buccal tablet (Fentora) for breakthrough pain.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):78-9. PubMed ID: 17878889
    [No Abstract]   [Full Text] [Related]  

  • 12. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J; Rothman M
    Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
    Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
    Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sticking to the safe side with fentanyl patches.
    D'Arcy Y
    Nursing; 2009 Mar; 39(3):62-3. PubMed ID: 19247136
    [No Abstract]   [Full Text] [Related]  

  • 15. Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective, multicenter pilot study in outpatients with chronic pain.
    Freynhagen R; von Giesen HJ; Busche P; Sabatowski R; Konrad C; Grond S
    J Pain Symptom Manage; 2005 Sep; 30(3):289-97. PubMed ID: 16183013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
    Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
    J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opioid induction using rapid release drugs and the shift to fentanyl patches].
    Sasaki S; Morohashi T; Otsuka Y; Ejima M; Tsujikawa Y; Yoshimura K; Terai E; Suzuki N; Nakayama H; Watanabe T
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):863-7. PubMed ID: 25131873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
    Slatkin NE; Xie F; Messina J; Segal TJ
    J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety alert for fentanyl buccal tablets.
    U.S. Food and Drug Administration
    J Pain Palliat Care Pharmacother; 2008; 22(1):47. PubMed ID: 19062355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.